Effectiveness of Using Weissella Cibaria CMU Bacteries as Oral Probiotics for Halitosis Therapy: A Scoping Review

Abstract

Halitosis is an unpleasant odor that is produced during exhalation, originating both inside and outside the oral cavity with volatile sulphur compound (VSC) as the main component. VSC is produced as a result of protein degradation by gram-negative anaerobic pathogenic bacteria. Halitosis poses a problem in the field of dentistry and has an impact on the psychosocial well-being of patients. Current halitosis therapy through conventional mechanical and chemotherapeutic methods still has obstacles, so it is necessary to look for alternative therapies that are safer and more effective, including through the use of Weissella cibaria CMU bacteria as an oral probiotic. Clinical investigations on humans have provided just a small amount of data on the efficacy of Weissella cibaria CMU as an oral probiotic for the treatment of halitosis. Purpose of this article to analyze the effectiveness of Weissella cibaria CMU as an oral probiotic for halitosis therapy from various human clinical studies. Preferred Reporting Item Guidelines for Methods of Systematic Review and Meta Analysis (PRISMA) selection process for articles. The articles were sourced from PubMed, Google Scholar and ResearchGate databases for the period 2013-2023 using the Boolean search "halitosis" AND "oral probiotics" AND "Weissella cibaria." The inclusion and exclusion criteria were used for a total of 4 articles, which were then reviewed. Clinical studies have shown that Weissella cibaria CMU can be used as an oral probiotic to improve halitosis. It is also safe for the body and health, thus it may be considered of as a support option for halitosis therapy.